Marshall Wace North America’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $48.9M | Buy |
826,880
+169,274
| +26% | +$10M | 0.21% | 99 |
|
|
2021
Q2 | $43.9M | Sell |
657,606
-2,439,729
| -79% | -$163M | 0.18% | 119 |
|
|
2021
Q1 | $196M | Sell |
3,097,335
-741,084
| -19% | -$46.8M | 0.81% | 15 |
|
|
2020
Q4 | $238M | Buy |
3,838,419
+2,991,635
| +353% | +$186M | 1.07% | 11 |
|
|
2020
Q3 | $51.1M | Buy |
846,784
+833,809
| +6,426% | +$50.3M | 0.33% | 69 |
|
|
2020
Q2 | $763K | Buy |
+12,975
| New | +$763K | 0.01% | 831 |
|
|
2020
Q1 | – | Sell |
-45,494
| Closed | -$2.92M | – | 1242 |
|
|
2019
Q4 | $2.92M | Sell |
45,494
-86,932
| -66% | -$5.58M | 0.01% | 492 |
|
|
2019
Q3 | $6.72M | Sell |
132,426
-5,804
| -4% | -$294K | 0.04% | 314 |
|
|
2019
Q2 | $6.27M | Sell |
138,230
-423,615
| -75% | -$19.2M | 0.04% | 315 |
|
|
2019
Q1 | $26.8M | Buy |
561,845
+116,315
| +26% | +$5.55M | 0.19% | 115 |
|
|
2018
Q4 | $23.2M | Buy |
445,530
+258,957
| +139% | +$13.5M | 0.22% | 92 |
|
|
2018
Q3 | $11.6M | Sell |
186,573
-1,294,757
| -87% | -$80.4M | 0.08% | 196 |
|
|
2018
Q2 | $82M | Buy |
1,481,330
+7,476
| +0.5% | +$414K | 0.46% | 48 |
|
|
2018
Q1 | $93.2M | Buy |
1,473,854
+1,252,722
| +567% | +$79.2M | 0.47% | 48 |
|
|
2017
Q4 | $13.6M | Sell |
221,132
-861,196
| -80% | -$52.8M | 0.07% | 311 |
|
|
2017
Q3 | $69.3M | Buy |
1,082,328
+851,692
| +369% | +$54.5M | 0.44% | 38 |
|
|
2017
Q2 | $12.9M | Buy |
230,636
+95,927
| +71% | +$5.37M | 0.09% | 262 |
|
|
2017
Q1 | $7.27M | Buy |
+134,709
| New | +$7.27M | 0.06% | 321 |
|
|
2013
Q4 | $268K | Buy |
+5,039
| New | +$268K | 0.01% | 615 |
|